Acquisition by Denner Alexander J of 10000 shares of Innoviva at 13.0538 subject to Rule 16b-3
INVA Stock | USD 19.12 0.13 0.68% |
About 64% of all Innoviva's investors are looking to take a long position. The analysis of overall sentiment of trading Innoviva stock suggests that some investors are interested at this time. The current market sentiment, together with Innoviva's historical and current headlines, can help investors time the market. In addition, many technical investors use Innoviva stock news signals to limit their universe of possible portfolio assets.
Innoviva |
Filed transaction by Innoviva 10 Percent Owner. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Read at businesswire.com
Innoviva Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Innoviva can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Innoviva Fundamental Analysis
We analyze Innoviva's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Innoviva using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Innoviva based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
EBITDA
EBITDA Comparative Analysis
Innoviva is currently under evaluation in ebitda category among its peers. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Innoviva Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Innoviva stock to make a market-neutral strategy. Peer analysis of Innoviva could also be used in its relative valuation, which is a method of valuing Innoviva by comparing valuation metrics with similar companies.
Peers
Innoviva Related Equities
APLS | Apellis Pharmaceuticals | 4.39 | ||||
ABOS | Acumen Pharmaceuticals | 3.52 | ||||
INZY | Inozyme Pharma | 2.95 | ||||
DNLI | Denali Therapeutics | 2.52 | ||||
HOOK | Hookipa Pharma | 2.38 | ||||
HRMY | Harmony Biosciences | 1.33 | ||||
ARGX | Argenx NV | 0.25 | ||||
AMLX | Amylyx Pharmaceuticals | 0.18 | ||||
FOLD | Amicus Therapeutics | 0.20 | ||||
DAWN | Day One | 0.65 | ||||
TERN | Terns Pharmaceuticals | 1.44 | ||||
INCY | Incyte | 1.81 | ||||
PDSB | PDS Biotechnology | 1.83 | ||||
PLX | Protalix Biotherapeutics | 2.91 | ||||
ELEV | Elevation Oncology | 3.13 | ||||
XFOR | X4 Pharmaceuticals | 5.13 |
Complementary Tools for Innoviva Stock analysis
When running Innoviva's price analysis, check to measure Innoviva's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innoviva is operating at the current time. Most of Innoviva's value examination focuses on studying past and present price action to predict the probability of Innoviva's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Innoviva's price. Additionally, you may evaluate how the addition of Innoviva to your portfolios can decrease your overall portfolio volatility.
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories |